Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-09-22
1994-02-22
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544267, A61K 3152, C07D47304
Patent
active
052887219
ABSTRACT:
Compounds of the formula ##STR1## including the resolved enantiomers and/or diastereomers and mixtures thereof wherein each of one or two R is independently ##STR2## wherein n is 1-16 and R' is H or alkyl(1-4C); and wherein each remaining R is independently H, alkyl(1-6C), alkenyl(1-6C) or benzyl; an wherein said alkyl or alkenyl may be substituted by a hydroxyl, halo, or dimethylamino group, and/or interrupted by an oxygen atom, are useful in modulating the effects of internal and external stimuli on cells by reversing the effects of these stimuli on the short-term secondary messenger pathways. In particular, the compounds lower elevated levels of unsaturated, non-arachidonate phosphatidic acid (PA) and diacylglycerol (DAG) derived from said PA within seconds of the primary stimulus and their contact with said cells. The modulatory effect depends on the nature of the target cell and the stimulus applied.
REFERENCES:
patent: 3373433 (1973-06-01), Mohler et al.
patent: 3422107 (1969-01-01), Mohler et al.
patent: 4031218 (1977-06-01), El-Antably
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4833146 (1989-05-01), Gebert et al.
patent: 4960773 (1990-10-01), Korbonits et al.
patent: 4965271 (1990-10-01), Mandell et al.
patent: 5039666 (1991-08-01), Novick, Jr.
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5175291 (1992-12-01), Kufner-Muhl
Fisher et al., Arzneim-Forsch/Drug Res., 34(1) No. 6; p 666; 1984.
Davis et al., Applied Environment. Microbiol. (1984) 48:327-331.
Klein J. Peter
Porubek David
Rice Glenn C.
Woodson Paul
Cell Therapeutics Inc.
Ford John M.
Murashige Kate H.
Oster Jeffrey B.
Sripada P. K.
LandOfFree
Substituted epoxyalkyl xanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted epoxyalkyl xanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted epoxyalkyl xanthines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-171371